Treprostinil controlled release (Camurus)

曲前列尼尔控释制剂 (Camurus)

Report date: 2024/01/26 17:42:59

Base Information

Drug NameTreprostinil controlled release (Camurus)
Drug Alias NameCAM-2043CAM2043
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProstanoid IP receptor agonistsPlatelet aggregation inhibitors
TargetsProstanoid IP receptor
Therapy Area/IndicationsRaynaud DiseasePulmonary Arterial Hypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesCamurus Ab
China Registration ClassN/A

Develop Information

Active CompaniesCamurus Ab
Inactive CompaniesN/A
Active IndicationsRaynaud DiseasePulmonary Arterial Hypertension
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A